Fundz

Gfbiochemicals Raises €15M Series A To Advance Its Mission To End Chemical Pollution

PRIVATEMay 05, 2022

Amount Raised

€15 Million

Round Type

Series A

Paris

Description

PARIS, FRANCE / May 5, 2022 / GFBiochemicals, a leading sustainable chemical company, today announced a €15 million Series A funding round led by Sofinnova Partners, with participation from Sparta Capital. At a time when the chemical crisis has already passed the safe limit for human health and the environment, the round will accelerate GFBiochemicals' mission to end chemical pollution. The company aims to help fast moving consumer goods (FMCG) and industrial companies transition away from using toxic, environmentally harmful petrochemicals in everyday products.

Who to call at Gf Biochemicals, and when

A new round usually means Gf Biochemicals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gf Biochemicals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gf Biochemicals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gf Biochemicals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gf Biochemicals

Location

Paris, Ile-de-France, France

About

Headquartered in Paris, GFBiochemicals is a leading sustainable chemical company with a mission to end chemical pollution. We provide the companies who make our everyday products with safe, sustainable solvents and ingredients derived from the biobased levulinic molecule. This has three benefits: it ensures that everyday products are biodegradable, non-harmful and carbon friendly. GFBiochemicals has offices and R&D facilities in the Netherlands and the United States, operations in India, and over 200 active patents across 40 patent families. Through our Joint Venture, NXTLEVVEL, we leverage our proprietary technology to enable commercial-scale manufacturing of our product. For more information, please visit: http://www.gfbiochemicals.com/company/.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gf Biochemicals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Gf Biochemicals's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Gf Biochemicals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.